Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, recently announced it has received CE Mark for its self-expanding CENTERA valve for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery.
Arterys Inc., the leader in intelligent, cloud-based medical imaging software solutions, recently announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA).
BD (Becton, Dickinson and Company), a leading global medical technology company, recently reported quarterly revenues of $3.080 billion for the first fiscal quarter ended December 31, 2017.
Global healthcare design, strategy and innovation firm, Worrell, Inc. announced it will join Kaiser Permanente, Medical Group Management Association, Delta Dental, Prime Health, University of Colorado, AngelMD and dozens of health tech startups in Catalyst HTI, a new Denver health-care innovation hub opening June of this year. Catalyst HTI is the first facility of its kind in the United States, designed to bring together stakeholders from across the healthcare market to foster collaboration and accelerate innovation.
Empatica Inc has received clearance from the FDA for Embrace, its award-winning smart watch. Embrace uses AI (advanced machine learning) to monitor for the most dangerous kinds of seizures, known as "grand mal" or "generalized tonic-clonic" seizures, and send an alert to summon caregivers' help.
For the first time, researchers have fabricated sensing elements known as fiber Bragg gratings inside optical fibers designed to dissolve completely inside the body.
Varian recently announced it has acquired privately-held Mobius Medical Systems®, a leader in radiation oncology Quality Assurance (QA) software.
Outsourced Pharma announces its Philadelphia agenda. Fundamentals for Outsourcing Drug Development and Manufacturing is scheduled for July 18 and 19, 2018 in Philadelphia.
Phillips-Medisize, a Molex company will showcase its continuum of contract services including device strategy, product development and manufacture across pharmaceutical primary packaging and specialty drug delivery devices, dosing & dispensing systems, inhalators, spray applicators, as well as wearable drug delivery devices designed to improve patient engagement and drive better outcomes.
|
|
|
|
|
|
|
|
|